Switzerland· 55945001
Vfend 200 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
A voriconazole product, registered in Switzerland by Pfizer AG and dispensed under Swissmedic category A. The same ATC class is registered in 18 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Voriconazole is registered in 18 of 19 countries.
Countries holding a registration under ATC J02AC03 (voriconazole), each read from that country’s own register.
- This record: Switzerland
- 10 of them publish a price we can compare per daily dose
Voriconazole · ATC J02AC03
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of voriconazole costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $0.14 in Czechia to $86.21 in Switzerland — a ×609 gap.
- Switzerland: $86.21 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Voriconazole · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$86.21
- FR France$38.90
- IT Italy$12.20
- US United States$3.77 (acquisition cost)
- CZ Czechia$0.14
The record
At a glance
- Manufacturer
- Pfizer AG
- Country
- Switzerland (CH)
- ATC code
- J02AC03
- ATC class
- Voriconazole
- Defined daily dose
- 0.4 g, O
- Swissmedic category
- A
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
513 interactions on record for voriconazole.
Graded by severity as the source publishes them — 161 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Voriconazole · interactions on record
513 records
- 161 severe
- 229 moderate
- 10 minor
- 48 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NaloxegolA06AH03severe
65 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J02AC03
Voriconazole, as other registers publish it.
- CanadaJAMP VORICONAZOLEJAMP PHARMA CORPORATION
- CanadaJAMP VORICONAZOLEJAMP PHARMA CORPORATION
- CanadaSANDOZ VORICONAZOLESANDOZ CANADA INCORPORATED
- CanadaSANDOZ VORICONAZOLESANDOZ CANADA INCORPORATED
- BelgiumSpionic 200 mgPfizer
- BelgiumSpionic 200 mgPfizer
- BelgiumSpionic 40 mg/mlPfizer
- BelgiumSpionic 50 mgPfizer
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d1bc0930-e8c2-4d1d-9c6a-17b6a697e603 GET /v1/drugs/d1bc0930-e8c2-4d1d-9c6a-17b6a697e603?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about voriconazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.